95 related articles for article (PubMed ID: 12050209)
1. ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell lines.
Portella G; Scala S; Vitagliano D; Vecchio G; Fusco A
J Clin Endocrinol Metab; 2002 Jun; 87(6):2525-31. PubMed ID: 12050209
[TBL] [Abstract][Full Text] [Related]
2. Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells.
Yeung SC; Xu G; Pan J; Christgen M; Bamiagis A
Cancer Res; 2000 Feb; 60(3):650-6. PubMed ID: 10676649
[TBL] [Abstract][Full Text] [Related]
3. ONYX-015 enhances radiation-induced death of human anaplastic thyroid carcinoma cells.
Portella G; Pacelli R; Libertini S; Cella L; Vecchio G; Salvatore M; Fusco A
J Clin Endocrinol Metab; 2003 Oct; 88(10):5027-32. PubMed ID: 14557490
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo.
Nagayama Y; Yokoi H; Takeda K; Hasegawa M; Nishihara E; Namba H; Yamashita S; Niwa M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4081-6. PubMed ID: 11095436
[TBL] [Abstract][Full Text] [Related]
5. ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice.
Reddi HV; Madde P; Reichert-Eberhardt AJ; Galanis EC; Copland JA; McIver B; Grebe SK; Eberhardt NL
Cancer Gene Ther; 2008 Nov; 15(11):750-7. PubMed ID: 18583996
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab increases viral distribution in human anaplastic thyroid carcinoma xenografts and enhances the effects of E1A-defective adenovirus dl922-947.
Libertini S; Iacuzzo I; Perruolo G; Scala S; Ieranò C; Franco R; Hallden G; Portella G
Clin Cancer Res; 2008 Oct; 14(20):6505-14. PubMed ID: 18927290
[TBL] [Abstract][Full Text] [Related]
7. Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas.
Shinoura N; Yoshida Y; Tsunoda R; Ohashi M; Zhang W; Asai A; Kirino T; Hamada H
Cancer Res; 1999 Jul; 59(14):3411-6. PubMed ID: 10416603
[TBL] [Abstract][Full Text] [Related]
8. Treatment of aggressive thyroid cancer with an oncolytic herpes virus.
Yu Z; Eisenberg DP; Singh B; Shah JP; Fong Y; Wong RJ
Int J Cancer; 2004 Nov; 112(3):525-32. PubMed ID: 15382081
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic usefulness of wild-type p53 gene introduction in a p53-null anaplastic thyroid carcinoma cell line.
Narimatsu M; Nagayama Y; Akino K; Yasuda M; Yamamoto T; Yang TT; Ohtsuru A; Namba H; Yamashita S; Ayabe H; Niwa M
J Clin Endocrinol Metab; 1998 Oct; 83(10):3668-72. PubMed ID: 9768682
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic activity of taxol against human anaplastic thyroid carcinoma cell lines in vitro and in vivo.
Ain KB; Tofiq S; Taylor KD
J Clin Endocrinol Metab; 1996 Oct; 81(10):3650-3. PubMed ID: 8855817
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma.
Xu G; Pan J; Martin C; Yeung SC
J Clin Endocrinol Metab; 2001 Apr; 86(4):1769-77. PubMed ID: 11297616
[TBL] [Abstract][Full Text] [Related]
12. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.
Geoerger B; Grill J; Opolon P; Morizet J; Aubert G; Terrier-Lacombe MJ; Bressac De-Paillerets B; Barrois M; Feunteun J; Kirn DH; Vassal G
Cancer Res; 2002 Feb; 62(3):764-72. PubMed ID: 11830531
[TBL] [Abstract][Full Text] [Related]
14. An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.
Iuliano R; Trapasso F; Le Pera I; Schepis F; Samà I; Clodomiro A; Dumon KR; Santoro M; Chiariotti L; Viglietto G; Fusco A
Cancer Res; 2003 Feb; 63(4):882-6. PubMed ID: 12591742
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy including combretastatin A4 phosphate and paclitaxel is effective against anaplastic thyroid cancer in a nude mouse xenograft model.
Yeung SC; She M; Yang H; Pan J; Sun L; Chaplin D
J Clin Endocrinol Metab; 2007 Aug; 92(8):2902-9. PubMed ID: 17550961
[TBL] [Abstract][Full Text] [Related]
16. A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer.
Ganly I; Kirn D; Eckhardt G; Rodriguez GI; Soutar DS; Otto R; Robertson AG; Park O; Gulley ML; Heise C; Von Hoff DD; Kaye SB
Clin Cancer Res; 2000 Mar; 6(3):798-806. PubMed ID: 10741699
[TBL] [Abstract][Full Text] [Related]
17. Replication and cytolysis of an E1B-attenuated adenovirus in drug-resistant ovarian tumour cells is associated with reduced apoptosis.
Ganly I; Kim YT; Hann B; Balmain A; Brown R
Gene Ther; 2001 Mar; 8(5):369-75. PubMed ID: 11313813
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism.
Shih A; Davis FB; Lin HY; Davis PJ
J Clin Endocrinol Metab; 2002 Mar; 87(3):1223-32. PubMed ID: 11889192
[TBL] [Abstract][Full Text] [Related]
19. [Anti-tumor effect of E1B55kDa-deleted adenovirus on human hepatocellular carcinoma cell lines].
Zhao J; Lü Y; Guo Y
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):366-8. PubMed ID: 11810762
[TBL] [Abstract][Full Text] [Related]
20. Treatment of human thyroid carcinoma cells with the g47delta oncolytic herpes simplex virus.
Wang JN; Xu LH; Zeng WG; Hu P; Rabkin SD; Liu RR
Asian Pac J Cancer Prev; 2015; 16(3):1241-5. PubMed ID: 25735362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
